初次内镜检查阴性后巴雷特食管的患病率与预测因素:两项国家数据库分析
基于GIQuIC和TriNetX两个国家数据库,纳入至少接受两次食管胃十二指肠镜(EGD)且初次EGD阴性的患者,重复EGD时巴雷特食管(BE)患病率为1.7%-3.4%,多数为无异型增生BE,患病率随危险因素数量增加而升高。作者认为多数BE可能在初次检查时被漏诊,不推荐常规重复内镜筛查,但可考虑对胃食管反流病且≥2项BE危险因素的患者进行重复筛查。
要点
- 初次EGD阴性后重复EGD的BE患病率为1.7%(GIQuIC)和3.4%(TriNetX),其中89%为无异型增生BE。
- BE患病率在初次阴性EGD后1至>5年间保持稳定,但随危险因素数量增加而升高。
- 胃食管反流病合并≥1项BE危险因素的高危人群BE患病率为3%-4%。
核心结论
- 在超过35万例患者中,重复EGD的BE患病率为1.7%-3.4%,多危险因素者更高,多数BE可能在初次评估时被漏诊。
- 不推荐初次检查阴性后常规重复内镜BE筛查,但可考虑对胃食管反流病且≥2项BE危险因素的患者重复筛查,或使用非内镜工具。
研究设计与样本
- 基于GI Quality Improvement Consortium(GIQuIC)和TriNetX两个国家数据库的分析,纳入至少接受2次EGD的患者,排除初次EGD检出BE或食管腺癌者。
- GIQuIC队列214,318例,TriNetX队列153,445例,中位随访28-35个月。
- 采用多变量逻辑回归评估重复EGD检出BE的独立危险因素。
主要发现
- 重复EGD时BE患病率在GIQuIC为1.7%,在TriNetX为3.4%,分别为基线BE患病率的26%-45%。
- 89%的患者为无异型增生BE。
- BE患病率在初次阴性EGD后1年至>5年间保持稳定,但随危险因素数量增加而升高。
- 胃食管反流病合并≥1项BE危险因素的高危人群BE患病率为3%-4%。
临床怎么用
- 不推荐初次内镜检查阴性后常规重复内镜进行BE筛查。
- 可考虑对胃食管反流病且≥2项BE危险因素的患者进行重复筛查,可能使用非内镜工具。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Guidelines suggest a single screening esophagogastroduodenoscopy (EGD) in patients with multiple risk factors for Barrett's esophagus (BE). We aimed to determine BE prevalence and predictors on repeat EGD after a negative initial EGD, using 2 large national databases (GI Quality Improvement Consortium [GIQuIC] and TriNetX). METHODS: Patients who underwent at least 2 EGDs were included and those with BE or esophageal adenocarcinoma detected at initial EGD were excluded. Patient demographics and prevalence of BE on repeat EGD were collected. Multivariate logistic regression was performed to assess for independent risk factors for BE detected on the repeat EGD. RESULTS: In 214,318 and 153,445 patients undergoing at least 2 EGDs over a median follow-up of 28-35 months, the prevalence of BE on repeat EGD was 1.7% in GIQuIC and 3.4% in TriNetX, respectively (26%-45% of baseline BE prevalence). Most (89%) patients had nondysplastic BE. The prevalence of BE remained stable over time (from 1 to >5 years from negative initial EGD) but increased with increasing number of risk factors. BE prevalence in a high-risk population (gastroesophageal reflux disease plus ≥1 risk factor for BE) was 3%-4%. CONCLUSIONS: In this study of >350,000 patients, rates of BE on repeat EGD ranged from 1.7%-3.4%, and were higher in those with multiple risk factors. Most were likely missed at initial evaluation, underscoring the importance of a high-quality initial endoscopic examination. Although routine repeat endoscopic BE screening after a negative initial examination is not recommended, repeat screening may be considered in carefully selected patients with gastroesophageal reflux disease and ≥2 risk factors for BE, potentially using nonendoscopic tools.
引用
- Dhaliwal L, Kamboj AK, Williams JL, et al. Prevalence and Predictors of Barrett's Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases. Clin Gastroenterol Hepatol. 2023. PMID: 37716614. doi:10.1016/j.cgh.2023.08.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。